Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 383-390 , May 2007

Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor

  • Jai Woong Seo

      Affiliations

    • Department of Chemistry, Inha University, Inchon 402-751, Korea
    • ,
  • Dae Yoon Chi

      Affiliations

    • Department of Chemistry, Inha University, Inchon 402-751, Korea
    • ,
  • Carmen S. Dence

      Affiliations

    • Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
    • ,
  • Michael J. Welch

      Affiliations

    • Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
    • ,
  • John A. Katzenellenbogen

      Affiliations

    • Department of Chemistry, Box 37-5, University of Illinois, Urbana, IL 61801, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 217 333 6310; fax: +1 217 333 7325.

Received 29 November 2006 ,Revised 24 January 2007 ,Accepted 29 January 2007.

References 

  1. Katzenellenbogen JA. Drugs Pharmaceut Sci. 1992;55:297–331
  2. Katzenellenbogen JA. Designing steroid receptor-based radiotracers to image breast and prostate tumors. J Nucl Med. 1995;36:8S–13S
  3. Van de Wiele C, De Vos F, Slegers G, Van Belle S, Dierckx RA. Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review. Eur J Nucl Med. 2000;27:1421–1433
  4. Andersonm RE, Holt JA. Binding of radiolabeled estrogens by human cells in vitro: implications to the development of a new diagnostic and therapeutic modality in the treatment of malignancies with estrogen receptors. Gynecol Oncol. 1989;34:80–83
  5. De Hertogh R, Ekka E, Vanderheyden I, Hoet JJ. In vivo observations on reversible binding of estradiol-17β,6,7-3H in rat uterus. Measurement of a biological exchange constant and of the tissue capacity. Endocrinology. 1971;88:165–174
  6. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, et al. Breast cancer: PET imaging of estrogen receptors. Radiology. 1988;169:45–48
  7. Katzenellenbogen JA, Senderoff SG, McElvany KD, O'Brien HA, Welch MJ. 16a-[Bromine-77]bromoestradiol-17β: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors. J Nucl Med. 1981;22:42–47
  8. McElvany KD, Katzenellenbogen JA, Shafer KE, Siegel BA, Senderoff SG, Welch MJ. 16 alpha-[77Br]Bromoestradiol: dosimetry and preliminary clinical studies. J Nucl Med. 1982;23:425–430
  9. Rijks LJM, van den Bos JC, van Doremalen PAPM, Boer GJ, de Bruin K, Doornbos T, et al. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17α,20E)-21-[123I]iodo-11β-nitrαto-19-norpregna-1,3,5(10),20-tetraene-3,17-diol (E-[123I]NIVE). Nucl Med Biol. 1998;25:411–421
  10. Pomper MG, Van Brocklin H, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, et al. 11 beta-Methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. J Med Chem. 1990;33:3143–3155
  11. Seimbille Y, Benard F, van Lier JE. Synthesis of 16α-fluoro ICI 182,780 derivatives: powerful antiestrogens to image estrogen receptor densities in breast cancer by position emission tomography. J Chem Soc Perkin Trans. 2002;20:2275–2281
  12. VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ. 16 beta-([18F]Fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. J Med Chem. 1993;36:1619–1629
  13. Bergmann KE, Landvatter SW, Rocque PG, Carlson KE, Welch MJ, Katzenellenbogen JA. Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents. Nucl Med Biol. 1994;21:25–39
  14. Lashley MR, Niedzinski EJ, Rogers JM, Denison MS, Nantz MH. Synthesis and estrogen receptor affinity of a 4-hydroxytamoxifen-labeled ligand for diagnostic imaging. Bioorg Med Chem. 2002;10:4075–4082
  15. Lee KC, Moon BS, Lee JH, Chung KH, Katzenellenbogen JA, Chi DY. Synthesis and binding affinities of fluoroalkylated raloxifenes. Bioorg Med Chem. 2003;11:3649–3658
  16. Yang DJ, Li C, Kuang LR, Price JE, Buzdar AU, Tansey W, et al. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues. Life Sci. 1994;55:53–67
  17. McDonnell DP, Connor CE, Wijayaratne A, Chang CY, Norris JD. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog Horm Res. 2002;57:295–316
  18. Silfen SL, Ciaccia AV, Bryant HU. Selective estrogen receptor modulators: tissue selectivity and differential uterine effects. Climacteric. 1999;2:268–283
  19. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863–870
  20. Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol. 2001;63:165–192
  21. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, et al. Pyrazole ligands: structure–affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem. 2000;43:4934–4947
  22. Mortensen DS, Rodriguez AL, Carlson KE, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha. J Med Chem. 2001;44:3838–3848
  23. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor-beta potency-selective ligands: structure–activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 2001;44:4230–4251
  24. Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes. J Med Chem. 1999;42:2456–2468
  25. Muthyala RS, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J Med Chem. 2003;46:1589–1602
  26. Vijaykumar D, Al-Qahtani MH, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F]propyl pyrazole triol. Nucl Med Biol. 2003;30:397–404
  27. Yoo J, Dence CS, Sharp TL, Katzenellenbogen JA, Welch MJ. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol. J Med Chem. 2005;48:6366–6378
  28. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol. 2003;17:203–208
  29. Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction. Biochemistry. 1997;36:14897–14905
  30. Acharya U, Irvine DS, Hamilton MP, Templeton AA. The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm-cervical mucus interaction in ovulatory women. Hum Reprod. 1993;8:437–441
  31. Garg S, Bindal RD, Durani S, Kapil RS. Structure–activity relationship of estrogens: a study involving cyclofenyl as the model compound. J Steroid Biochem. 1983;18:89–95
  32. Tojo S, Hayashi K, Osawa E. Stimulation of ovulation with F-6066 cyclofenil: bis-(p-acetoxyphenyl)-cyclohexylidenemethane. Acta Obstet Gynecol Scand. 1973;52:335–3343
  33. Seo JW, Comninos JS, Chi DY, Kim DW, Carlson KE, Katzenellenbogen JA. Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure–affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer. J Med Chem. 2006;49:2496–2511
  34. Pangborn AB, Giardello MA, Grubbs RH, Rosen RK, Timmers FJ. Safe and convenient procedure for solvent purification. Organometallics. 1996;15:1518–1520
  35. Kilbourn MR, Jerabek PA, Welch MJ. An improved [18O]water target for [18F]fluoride production. Int J Appl Radiat Isot. 1985;36:327–328
  36. Senderoff SG, McElvany KD, Carlson KE, Heiman DF, Katzenellenbogen JA, Welch MJ. Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals. Int J Appl Radiat Isot. 1982;33:545–551
  37. Sharp TL, Dence CS, Engelbach JA, Herrero P, Gropler RJ, Welch MJ. Techniques necessary for multiple tracer quantitative small-animal imaging studies. Nucl Med Biol. 2005;32:875–884
  38. Katzenellenbogen JA, Mathias CJ, VanBrocklin HF, Brodack JW, Welch MJ. Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. Nucl Med Biol. 1993;20:735–745
  39. Landvatter SW, Katzenellenbogen JA, McElvany KD, Welch MJ. (2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo. J Med Chem. 1982;25:1307–1312
  40. Bonasera TA, O'Neil JP, Xu M, Dobkin JA, Cutler PD, Lich LL, et al. Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. J Nucl Med. 1996;37:1009–1015
  41. Fortunati N. Sex hormone-binding globulin: not only a transport protein. What news is around the corner?. J Endocrinol Invest. 1999;22:223–234
  42. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122:751–762
  43. Porto CS, Lazari MF, Abreu LC, Bardin CW, Gunsalus GL. Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol. 1995;53:561–565
  44. DeSombre ER, Mease RC, Hughes A, Harper PV, DeJesus OT, Friedman AM. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers. Cancer Res. 1988;48:899–906

PII: S0969-8051(07)00038-8

doi: 10.1016/j.nucmedbio.2007.01.010

Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 383-390 , May 2007

Article Tools

* Image Usage & Resolution